Log in
Log in
Or log in with
GoogleGoogle
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Robert Landry
Age : 58
Public asset : 24,932,303 USD
Country of residence : Unknown
Linked companies : Regeneron Pharmaceuticals, Inc. - Checkmate Pharmaceuticals, Inc. - Decibel Therapeutics, Inc.

Biography of Robert Landry 
Robert E. Landry is Chief Financial Officer & Executive VP-Finance at Regeneron Pharmaceuticals, Inc. He previously was Treasurer & Senior Vice President at Pfizer Inc. Director-Pharmaceutical Marketing & Sales at Wyeth Australia Pty Ltd. Chief Financial Officer of Wyeth New Zealand and Treasurer & Principal Corporate Officer at Wyeth Corp. (which are all subsidiaries of Pfizer Inc.). Mr. Landry received an undergraduate degree from the University of Notre Dame.


Current positions of Robert Landry 
Holdings of Robert Landry 
Robert Landry : Personal Network 
Most Read News 
11/28Buffett's Berkshire countersues billionaire Haslams in battle over Pilot valuation
RE
11/28Charlie Munger, the 'Oracle of Pasadena' who was Buffett's second-in-command
RE
11/30Tesla to deliver Cybertrucks after Musk tempers expectations
MR
11/27Elon Musk, Netanyahu tour ruins of Israeli kibbutz
RE
11/22LVMH heir Antoine Arnault to step back from Berluti management role
RE
11/28Berkshire Hathaway vice chairman Charlie Munger dies at 99
RE
11/22Factbox-LVMH roles held by Bernard Arnault's children
RE
11/26Germany's Kuehne examines offer for Signa's Hamburg skyscraper -report
RE
11/30BP's search for new CEO to extend into next year as Looney probe drags on
RE
11/28Elon Musk promises to wear symbol of Gaza hostages
RE
More news


© 2023 People and Ownership :   
Robert Landry : Connections 


Latest news about Robert Landry 
11/28Transcript : Regeneron Pharmaceuticals, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 08:30 AM
CI
11/15Transcript : Regeneron Pharmaceuticals, Inc. Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-15-2023 02:30 PM
CI
11/02Transcript : Regeneron Pharmaceuticals, Inc., Q3 2023 Earnings Call, Nov 02, 2023
CI
09/11Regeneron Pharmaceuticals Chief Financial Officer to Retire in February
MT
09/11Regeneron Pharmaceuticals Finance Chief Robert Landry to Retire; Successor Named
MT
09/08Regeneron says CFO Landry to retire in February
RE
09/08Regeneron Finance Chief Robert Landry to Retire
DJ
More news

As early as today, start finding the best investment opportunities!Optimize my profits
Optimize my profits